1-(diazyn-1-ium-1-yl)-13-[(2,5-dioxopyrrolidin-1-yl)oxy]-13-oxo-4,7,10-trioxa-1-azatridecan-1-ide, 98%, 5g

6-BROMO-1-METHOXYNAPHTHALENE, 95%, 500mg

2-(4,7,10-TRIS(2-TERT-BUTOXY-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECAN-1-YL)ACETIC ACID, 95%, 10g

3-Amino-4-cyclobutyl-2-hydroxybutanamide Hydrochloride (mixture of diastereoisomers)>95.0%(T)250mg

1H-indazol-5-ol, 98%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoic acid, 98%, 100g

Pyridine-3,4-dicarbonitrile, 95+%, 250mg

Potassium fluoride, min. 99%, cryst., 250 g, plastic packaging.

7-amino-5-(3,4-dimethoxyphenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile, 1g

Chlorodimethylvinylsilane>97.0%(GC)100mL

2-Chloro-4-methylpyrimidine, 98.0%, 25g

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

2,2':6',2''-Terpyridine>98.0%(GC)(T)1g